Ledger.Open graph →
SEC Form D · filed July 26, 2019

TScan Therapeutics, Inc

Offering
$23.3M
Sold
$23.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Lea Hachigian · Boston, MADirectorDavid Southwell · Boston, MAExec · DirectorSteve Kraus · MANCHESTER, NHDirectorHannes Smarason · MOUNTAIN VIEW, CADirectorChristoph Westphal · Boston, MADirectorRobert Crane · Bedford, MAExecLea Hachigian · Boston, MADirectorDavid Southwell · Waltham, MAExec · DirectorSteve Kraus · Minneapolis, MNDirectorCampbell Murray · Cambridge, MADirectorHannes Smarason · MOUNTAIN VIEW, CADirectorChristoph Westphal · Boston, MADirectorRobert Crane · Cambridge, MAExecTimothy Barberich · Framingham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗